In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Sales | 3.7 | 1.0 | 0.3 | 0.5 | 0.3 | 0.3 | | 0.9 |
Sales growth | 614.3% | 234.0% | | -41.5% | -29.2% | -4.2% | | |
Cost of sales | 1.0 | 0.8 | 0.2 | 0.3 | 0.1 | 0.2 | 0.1 | |
|
Inventory write-down | | | | | | | | |
Gross profit | 1.6 | 0.2 | -0.5 | 0.2 | 0.2 | 0.1 | | |
Gross margin | 42.7% | 18.6% | -153.1% | 48.5% | 58.9% | 42.1% | | |
|
Operating Expenses | | | | | | | | |
Research and development and patents | 0.6 | 0.9 | 1.4 | 1.5 | 1.8 | 2.5 | 1.5 | 1.7 |
General and administrative | 1.4 | 1.4 | 1.6 | 1.7 | 1.9 | 1.8 | 1.4 | 1.6 |
Amortization and depreciation | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
Total operating expenses | 12.9 | 2.3 | 3.0 | 24.9 | 3.7 | 4.4 | 2.9 | 3.3 |
|
Other Income (Expense) | | | | | | | | |
Interest and other income | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Warrant modification expense | | | | -1.3 | | | | |
|
Foreign exchange loss | | | | | | | | |
Loss before income tax expense | -0.3 | -2.0 | -3.5 | -7.9 | -3.5 | | -3.0 | |
Net loss for the year | -0.3 | -2.0 | -3.5 | -7.9 | -3.5 | -4.3 | -3.0 | -3.3 |
|
Net loss per share for the year | | | | | | | | |
Basic and diluted (in Dollars per share) | $0.28 | ($0.60) | ($4.06) | ($13.04) | ($6.14) | ($0.31) | ($6.17) | ($37.96) |
|
Weighted average outstanding common shares | | | | | | | | |
Basic and diluted (in Shares) | 2.4 | 3.3 | 0.9 | 0.6 | 0.6 | 13.8 | 0.5 | 0.3 |